Restricted Access Essentials for Pharma

September 14, 2015

In the September issue of Pharmaceutical Executive, Lev Gerlovin addresses four main questions that US drugmakers must answer to cope with the evolving payer landscape given rising drug prices. To read the article, click the link below.

Related capabilities

Key contacts